跳到正文

Pluri Inc. 提交8-K,披露重大协议与未注册股权出售

SEC EDGAR 8-K·(美东 10月30日 08:30)· 2 天前

8-K - Pluri Inc. (0001158780) (Filer)

AI 导读

Pluri Inc.(CIK 0001158780)于2026年10月30日提交8-K,报告期为2026年10月21日,文件共14份。该8-K涉及第1.01项重大确定性协议的签订、第3.02项未注册股权证券出售、第8.01项其他事件及第9.01项财务报表和附件。公司地址为以色列海法MATAM先进技术园区5号楼。

报错 · 内容有误?请告诉我们。

正文 · 原文

Filing Date

2026-10-30

Accepted

2026-10-30 08:30:28

Documents

14

Period of Report

2026-10-21

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Mailing Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 5 HAIFA Israel

Business Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 5 HAIFA Israel 972-74-710-7171

Pluri Inc. (Filer) CIK: 0001158780 (see all company filings)

EIN.: 980351734 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-31392 | Film No.: 261504506
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

来源:SEC EDGAR 8-K · sec.gov